Saxenda
Every GLP-1 the FDA has approved, and the active ingredient inside each one.
What is Saxenda?
Liraglutide 3.0 mg, injected daily rather than weekly, approved for weight management in 2014.
Its half-life is about 13 hours, which is why it is dosed daily. It has been largely superseded commercially, and is priced accordingly.
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where Saxenda comes up on this site
On GLP Watchdog, Saxenda comes up in 21 research articles, 8 seller reviews and 4 tools.
Research that discusses it
- Appetite Suppressants: Every FDA-Approved Drug and What Its Label Shows
- Does Delaware Medicaid Cover Wegovy and Zepbound? Yes, With a Health-Condition Rule
- Does Mississippi Medicaid Cover Wegovy and Zepbound? Coverage, Criteria and Who Stays On
- How Long Can Zepbound, Wegovy and Ozempic Be Out of the Fridge?
- TRICARE, FEHB and PSHB: Who Covers Wegovy and Zepbound in 2026
- Which Drugs Are GLP-1s? Mounjaro, Trulicity, Phentermine and 25 More, Checked
- All 21 articles are on the research page
Drug pages
Tools that use it
Seller reviews that mention it
Other terms under Drugs and brands
Where the evidence lives
- The full GLP-1 glossary (150 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers